HIV AIDS Clinical Trial: A Phase IIIB, Randomized, Trial of Open-label Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) with another PI in Combination with Double-Blind Comparison of two Nucleoside Reverse Transcriptase Inhibitor (NRTI) or a different NRTI in Antiretroviral-NaWve Subjects

HIV AIDS Clinical Trial: This study at Rush University Medical Center in Chicago, Illinois, will assess the safety of a new experimental drug. The drug is one of the subtypes of the natural IL protein produced in the body.

HIV AIDS Clinical Trial HAART: The purpose of the research is to see if anti-HIV vaccine is safe and tolerable in subjects infected with HIV.

HIV Infection (Initial Therapy): A phase III, randomized, open-label study of initial therapy for HIV-1 infection

HIV/AIDS Clinical Trial: The study at Rush University Medical Center in Chicago, Illinois, will try to see if taking a nucleoside supplement is safe in HIV-infected persons and if it will reverse the loss of fat in the face, arms, legs, or buttocks.

HIV/AIDS Clinical Trial: The study is being done at Rush University Medical Center in Chicago, Illinois, to learn if treating people during early HIV infection is beneficial. This study will evaluate how safe and effective a combination of anti-HIV drugs is for people with recently acquired HIV infection.

Policosonal for Dyslipidemia in HIV: Policosonal for dyslipidemia in HIV